Finance entity
Pomerantz Law Firm is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Each story carries 4.3 original sources on average, compared with 2.6 for the broader beat in this window. Coverage clusters in markets, which accounts for 2 of those 3, with the remainder spread across 1 other category.
Last mentioned: Mar 26, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Pomerantz Law Firm is the most frequent co-covered peer, appearing in 2 of the 3 tracked stories. Each story carries 4.3 original sources on average, compared with 2.6 for the broader beat in this window. Coverage clusters in markets, which accounts for 2 of those 3, with the remainder spread across 1 other category. At 5.3, the average consequence score sits below the same-window beat average of 6.3. Across a 35-day span, the pace is roughly 0.6 stories per week. This profile follows 3 Finance stories mentioning Navan, Inc. across the period from February 20, 2026 to March 26, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 2823 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Navan, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Discovery Phase Begins
Courts likely to rule on motions to dismiss, leading to the exchange of internal corporate documents.
Lead Plaintiff Deadline (Estimated)
Expected window for investors to file motions to lead the class actions against RARE, MREO, and NAVAN.
Q4 2026 Earnings Release
Official release of fiscal year-end financial results and SEC filing.
Earnings Conference Call
Management discussed AI integration and 2027 guidance with analysts.
Coordinated Legal Alerts
Pomerantz Law Firm issues a series of reminders for class action deadlines across four major firms.
Director Election Filing
Navan filed an 8-K regarding the election of new directors to the board.
Navan (NAVN) concluded its fiscal 2026 with a Q4 earnings call highlighting the successful scaling of its AI-powered expense management platform. CEO Ariel Cohen and VP of Investor Relations Ryan Burkart detailed the company's progress in capturing global enterprise market share while moving toward GAAP profitability.
Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Ultragenyx Pharmaceutical, Fermi Inc., Mereo BioPharma, and Navan, Inc. These legal actions target alleged securities fraud and disclosure failures, setting critical deadlines for lead plaintiff applications.
Pomerantz Law Firm has initiated a series of investigations into seven companies, including Snowflake and Navan, regarding potential securities fraud and unlawful business practices. These probes target firms across the technology, finance, and healthcare sectors, signaling a heightened period of legal scrutiny for public entities.
Source: prnewswire.com · prnewswire.com
Navan, Inc. is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
